Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

US FDA accepts priority review for EMD Serono's application for avelumab

pharmaceutical-technologyMarch 02, 2017

Tag: Priority Review , avelumab

PharmaSources Customer Service